Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing

With several recent FDA approvals and a strong drug pipeline, the gene therapy market is coming of age and providing new hope for patients. As demand for these new therapies increases, a robust and scalable manufacturing process is critical. In this webinar, we will present an end user case study which illustrates the challenges and solutions to scale both the upstream and downstream process steps required to manufacture adenoviruses.

 

Participants will learn how to:

 

• Accelerate time to market for adenovirus manufacturing

• Design the process for scalability

• Reduce downstream processing time from 3 - 4 days to 1 day

Speakers

clive glover

Clive Glover, PhD

 

Senior Marketing Manager, Cell & Gene Therapy

Pall Biotech

Rachel Legmann

Rachel Legmann, PhD

 

Senior Manager, Process Development Services

Pall Biotech

Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing

Maximize Speed to Market Flexibility of Single-Use for Gene Therapy Manufacturing

더 Biotech 웨비나
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
December 2020
Servicios de Validación de Filtración y Single Use Technology

Biotech | Pall Corporation 웨비나 시리즈

¡Todo sobre los ensayos de validaciones para cumplir con los máximos estándares regulatorios!

Hablaremos sobre puntos cruciales de los servicios de validación, incluyendo:

1. Necesidad de validación

2. Cómo se realizan los ensayos de validación

3. Análisis de riesgo: re uso de filtros y toma de decisión en ensayos a realizar

4. Servicio de Validación Pall: documentación requerida para iniciar una cotización

¡No pierdas esta segunda oportunidad!

시청